1. Home
  2. ACRS vs TITN Comparison

ACRS vs TITN Comparison

Compare ACRS & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

N/A

Current Price

$3.45

Market Cap

529.9M

Sector

Health Care

ML Signal

N/A

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

N/A

Current Price

$19.91

Market Cap

561.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
ACRS
TITN
Founded
2012
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
561.5M
IPO Year
2015
2007

Fundamental Metrics

Financial Performance
Metric
ACRS
TITN
Price
$3.45
$19.91
Analyst Decision
Strong Buy
Buy
Analyst Count
12
4
Target Price
$9.82
★ $25.25
AVG Volume (30 Days)
★ 2.6M
123.4K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 69.01
N/A
EPS
★ N/A
N/A
Revenue
$1,683,000.00
★ $2,427,107,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.29
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.46
$13.21
52 Week High
$6.60
$26.90

Technical Indicators

Market Signals
Indicator
ACRS
TITN
Relative Strength Index (RSI) 39.18 33.47
Support Level $3.24 $19.42
Resistance Level $4.60 $20.35
Average True Range (ATR) 0.28 1.28
MACD -0.02 -0.35
Stochastic Oscillator 17.03 0.82

Price Performance

Historical Comparison
ACRS
TITN

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: